931TiP - PRISM: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma
| Autor: | Collinson, F., Brown, S., Buckley, H., Ainsworth, G., Howard, H., Poad, H., Carr, G., Banks, R.E., Brown, J., Velikova, G., Larkin, J., Nathan, P., Powles, T.B., Vasudev, N.S. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|